Bovie Medical Corporation (NYSEMKT:BVX) Can’t Be Less Risky. Short Interest Decreased

September 17, 2017 - By Winifred Garcia

 Bovie Medical Corporation (NYSEMKT:BVX) Can't Be Less Risky. Short Interest Decreased

Investors sentiment decreased to 1.53 in Q4 2016. Its down 0.91, from 2.44 in 2016Q3. It worsened, as 9 investors sold Bovie Medical Corporation shares while 6 reduced holdings. 11 funds opened positions while 12 raised stakes. 9.00 million shares or 42.24% more from 6.33 million shares in 2016Q3 were reported.
Oberweis Asset Management holds 65,000 shares or 0.07% of its portfolio. Northern, Illinois-based fund reported 88,338 shares. Blackrock Institutional Tru Communication Na holds 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 7,897 shares. Geode Cap Mngmt Ltd Liability Company reported 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). National Bank & Trust Of America Corporation De has invested 0% in Bovie Medical Corporation (NYSEMKT:BVX). Morgan Stanley holds 0% or 13,781 shares in its portfolio. Manatuck Hill Ptnrs Ltd Liability Com has invested 0.22% in Bovie Medical Corporation (NYSEMKT:BVX). Perkins Cap Inc accumulated 632,035 shares. Susquehanna Intll Gru Llp reported 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). 10,700 are owned by Commonwealth Equity Services. Globeflex Capital L P holds 0% or 200 shares in its portfolio. 5,428 are held by Deutsche Commercial Bank Ag. Moreover, Driehaus Management Lc has 0.07% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 521,516 shares. Moreover, Pura Vida Invs Ltd has 0.16% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 123,000 shares. Wasatch Inc reported 200,000 shares stake.

The stock of Bovie Medical Corporation (NYSEMKT:BVX) registered a decrease of 9.8% in short interest. BVX’s total short interest was 129,800 shares in September as published by FINRA. Its down 9.8% from 143,900 shares, reported previously. With 101,500 shares average volume, it will take short sellers 1 days to cover their BVX’s short positions. The short interest to Bovie Medical Corporation’s float is 0.56%.

The stock increased 10.53% or $0.3 on September 15, reaching $3.15. About 257,813 shares traded or 25.30% up from the average. Bovie Medical Corporation (NYSEMKT:BVX) has risen 28.74% since September 17, 2016 and is uptrending. It has outperformed by 12.04% the S&P500.

Bovie Medical Corporation is an energy medical device company. The company has market cap of $97.21 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.

More notable recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: Businesswire.com which released: “Bovie Medical Receives 510K Clearance for Its Cool-Coagâ„¢ Generator and Open …” on March 27, 2017, also Streetinsider.com with their article: “Form 8-K BOVIE MEDICAL Corp For: Sep 15” published on September 15, 2017, Seekingalpha.com published: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q4 2016 Results …” on March 10, 2017. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) were released by: Businesswire.com and their article: “Bovie Medical Corporation Reports Second Quarter 2017 Financial Results and …” published on August 02, 2017 as well as Businesswire.com‘s news article titled: “Bovie Medical Announce Sales Channel Partnership with CONMED for PlazXactâ„¢” with publication date: January 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: